Debate over the Exclusivity Period for Biologics in the Trans-Pacific Partnership

Published date22 July 2015
Law FirmPatterson Belknap Webb & Tyler LLP
AuthorNathan Monroe-Yavneh,Irena Royzman
Subject MatterAffordable Care Act,Biologics,Exclusive Dealing Agreements,Free Trade Agreement,Pharmaceutical Manufacturers,Pharmaceutical Patents,Political Debates,Sandoz v Amgen,Trans-Pacific Partnership

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT